You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 12, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
Stefano Merler1, Marco Ajelli1, Laura Fumanelli1
1Bruno Kessler Foundation, Trento, Italy.
Ring vaccination with the rVSV-ZEBOV vaccine shows high efficacy against Ebola virus disease. This strategy, combined with improved healthcare readiness, can contain outbreaks even with higher transmission rates.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: